BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6282069)

  • 21. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
    Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
    J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunohistochemical localization of prolactin-binding sites in R3327 rat prostatic cancer cells.
    Witorsch RJ
    Horm Res; 1979; 10(5):268-81. PubMed ID: 222664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A; Block NL; Stover BJ; Irvin GL
    Cancer Res; 1985 Mar; 45(3):1052-7. PubMed ID: 3971360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid phosphatase-producing androgen-independent subline of rat prostatic adenocarcinoma (Dunning R3327 tumor) in cell culture.
    Igarashi T; Isaka S; Miyauchi T; Hayata I; Shimazaki J
    Prostate; 1984; 5(1):113-22. PubMed ID: 6694915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.
    Gupta S; Ahmad N; Mohan RR; Husain MM; Mukhtar H
    Cancer Res; 1999 May; 59(9):2115-20. PubMed ID: 10232597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells.
    Bai G; Kasper S; Matusik RJ; Rennie PS; Moshier JA; Krongrad A
    J Androl; 1998; 19(2):127-35. PubMed ID: 9570735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chicken chorioallantoic membrane assay for the evaluation of the androgen responsiveness of prostatic tissue.
    Jarow JP; Marshall FF; Isaacs JT
    J Urol; 1986 Jun; 135(6):1312-8. PubMed ID: 2423713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 30. The Nb rat prostatic adenocarcinoma model system.
    Drago JR; Goldman LB; Maurer RE
    Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-independent polyamine metabolism of squamous cell carcinoma of the prostate.
    Shukla GS; Singhal RL
    Cell Biochem Funct; 1985 Jul; 3(3):185-92. PubMed ID: 3836020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy.
    Scalabrino G; Ferioli ME
    Cancer Detect Prev; 1985; 8(1-2):11-6. PubMed ID: 4064029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dunning adenocarcinoma in tissue culture: isolation of a cloned cell line, R3327H-G8-A1.
    Sestili MA; Norris JS; Lipschultz LI; Smith RG
    J Urol; 1982 Apr; 127(4):823-5. PubMed ID: 7040704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1.
    Eaton CL; Pierrepoint CG
    Prostate; 1988; 12(2):129-43. PubMed ID: 3368402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.